China Medicine Corporation
CHME · OTC
12/31/2009 | 12/31/2008 | 12/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 20.7% | 27.4% | 75.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 29.3% | 29% | 29.4% | 37.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 20.5% | 21.2% | 21.8% | 26.5% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 2.7% | 17% | 16.3% | 20% |
| EPS Diluted | 0.11 | 0.6 | 0.5 | 0.63 |
| % Growth | -81.7% | 20% | -20.6% | – |
| Operating Cash Flow | $0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | -$0 | -$0 |